Milan Zdravkovic, MD, PhD, chief medical officer of SNIPR Biome, discussed the company’s ongoing research on targeting E Coli in the blood with CRISPR-based medication.
Milan Zdravkovic, MD, PhD
Advertisement
Articles by Milan Zdravkovic, MD, PhD
Advertisement
